Active, not recruitingPhase 2NCT04800874
Study of BBP-418 in Patients With LGMD2I
Studying FKRP-related limb-girdle muscular dystrophy R9
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ML Bio Solutions, Inc.
- Principal Investigator
- Amy Harper, MDVirginia Commonwealth University
- Intervention
- BBP-418(drug)
- Enrollment
- 14 enrolled
- Eligibility
- 12-55 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Virginia Commonwealth University, Richmond, Virginia, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04800874 on ClinicalTrials.govOther trials for FKRP-related limb-girdle muscular dystrophy R9
Additional recruiting or active studies for the same condition.
See all trials for FKRP-related limb-girdle muscular dystrophy R9 →